NGS Automation Market Size, Share, Growth Analysis, By product type(Workstation/Robotic Platform, Reagents & Consumables), By application(Drug Discovery, Clinical Diagnostics), By sequencing type(Whole Genome, Exome), By End use(Hospitals, Diagnostic Laboratories) - Industry Forecast 2024-2031

NGS Automation Market Drivers

Increased Investment to Develop Healthcare Infrastructure to Boost Market Growth

• The increased demand for automation in NGS workflow, the prevalence of cancer, rising R&D spending, and rising healthcare costs are just a few of the reasons contributing to the expansion of this industry. Additionally, this market is anticipated to experience significant expansion due to the expanding uses of next-generation sequencing and the growing number of corporate partnerships to create library preparation techniques.

• NGS is a potent DNA sequencing method that can examine a genome in its entirety and find new viral variations. In the upcoming years, epidemiological research to differentiate between COVID-19, influenza, and other viruses is anticipated to heavily rely on NGS. These elements are anticipated to fuel the industry's expansion and increase its demand.

NGS Automation Market Restraints

High Cost with Installing Automation Workstations to Hinder Market Growth

• This market's growth is anticipated to be significantly constrained by the high cost of automation workstations. The main obstacles to the expansion of this industry include issues with regulation and uniformity in diagnostic testing, as well as the need for highly skilled employees to operate automation software.

• Any type of DNA sequencing, including NGS, is subject to legal and ethical considerations. In addition to concerns unique to a particular culture and group, these issues also include identifiability, releasing study findings, stereotyping, the appropriateness of consent, stigmatisation, inclusion, and differential benefit. In essence, these moral concerns restrain market expansion.